missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
BB700 Mouse Anti-Human CD45RO, Clone UCHL1 (RUO)
Beskrivelse
- The UCHL1 monoclonal antibody specifically binds to the 180 kDa isoform of CD45 (aka, the Leukocyte Common Antigen).
- CD45RO is a type I transmembrane glycoprotein that has cytoplasmic protein tyrosine phosphatase activity and functions in signal transduction pathways.
- This CD45 isoform does not include amino acid sequences encoded by the variable CD45 exons A, B, or C.
- CD45RO is expressed on most thymocytes, activated T cells, memory T cells, granulocytes and monocytes, but only on a proportion of resting T cells.
- CD45RO and CD45RA antibodies seem to define complementary, predominantly non-overlapping, populations in resting peripheral T cells, demonstrating heterogeneity within the CD8 and CD4 subpopulations.
- CD45RO binds to CD22.
- The antibody was conjugated to BD Horizon BB700, which is part of the BD Horizon Brilliant™ Blue family of dyes.
- It is a polymer-based tandem dye developed exclusively by BD Biosciences.
- With an excitation max of 485 nm and an emission max of 693 nm, BD Horizon BB700 can be excited by the 488 nm laser and detected in a standard PerCP-Cy™5.5 set (eg., 695/40-nm filter).
- This dye provides a much brighter alternative to PerCP-Cy5.5 with less cross laser excitation off the 405 nm and 355 nm lasers.
Tekniske data
Tekniske data
| Antigen | CD45RO |
| Applikationer | Flow Cytometry |
| Klassifikation | Monoclonal |
| Klon | UCHL1 |
| Konjugeret | Brilliant Blue 700 (BB700) |
| Værtsarter | Mouse |
| Mængde | 100 Tests |
| Regulatorisk status | RUO |
| Primær eller sekundær | Secondary |
| Testspecificitet | CD45RO |
| Vis mere |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?